Reports and Surveys | March 16, 2022

2021 Corporate Governance Report

The 2021 edition of Segal Marco Advisor's Corporate Governance Report provides a summary of the market environment for corporate governance, the 2021 proxy votes on the most common issues (including proxy voting statistics), and our 2022 proxy policy statement.

Together, this data and analysis paints a comprehensive portrait of corporate governance and our approach to proxy voting.

Get the Report

2021 Corporate Governance Report Download Now

What's new in the report

We've made three important updates to our proxy policy statement that take effect on March 1, 2022.

  1. For management proposals seeking shareholder approval of climate action plans, a vote will be cast in favour for plans that include specifics on several key factors, and against plans that lack detail or ambition.
  2. For management proposals to approve Special Purpose Acquisition Corporation (SPAC) merger transactions, a vote will be cast in favour when the stock of the merged entity will trade at a premium to the redemption value for public shareholders, and against where it trades at a discount.
  3. For shareholder proposals seeking to convert a corporation into a Public Benefit Corporation (PBC), a vote may be cast in favour when the entity ensures no shareholder rights are weakened and where the entity does not subordinate financial return for the public benefit.

In addition to the updates to our proxy policy statement, the report also analyzes the effect of DOL and SEC rulings, 2021 investor initiatives on environmental, social and corporate governance (ESG), a breakdown of our proxy votes and more.

See more insights

Senior Couple With Nordic Walking Poles Hiking In Snow Covered Winter Nature

Ontario’s Consultation on a New Funding Regime for MEPPs

Ontario’s Ministry of Finance proposes regulations for implementing a permanent target benefit framework for Multi-Employer Pension Plans (MEPPs).
Businessman Standing At Window In Conference Room

"2023: The Year of the Rabbit” Investment Outlook

As tough as 2022 was for financial assets, it has set up a very positive starting point for 2023. Get our insights in our latest Investment Outlook.
Male Pharmacist Assisting A Customer At The Prescription Counter

Ontario Drug Benefit Program Changes Biologics Coverage

Learn more about Ontario’s new policy on the use of biosimilars and see how this change might affect your plan.

Don't miss out. Join 16,000 others who already get the latest insights from Segal.